Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz Tablets

Get a Price/Quote

MOQ : 100 Packs

Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz Tablets Specification

Salt Composition
Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg, Efavirenz 600 mg

Dosage Form
Tablet

Indication
HIV infection

Feature
Fixed Dose Combination, Once daily dosing

Ingredients
Tenofovir Disoproxil Fumarate, Lamivudine, Efavirenz

Application
Antiretroviral therapy (ART) for HIV-1 infection in adults and adolescents

Physical Color/Texture
Film coated, capsule-shaped tablet

Storage Instructions
Store below 30C in a dry place, protect from light

Shelf Life
24 to 36 months

Packaging Type
Bottle or blister pack

Packaging Size
30 Tablets per bottle (common) or as per manufacturer

Storage Condition
Keep container tightly closed

Therapeutic Class
Antiretroviral (NRTI + NNRTI combination)

ATC Code
J05AR06

Route of Administration
Oral

Contraindications
Known hypersensitivity to any component, severe hepatic impairment

Drug Class
Nucleoside/Nucleotide Reverse Transcriptase Inhibitor and Non-Nucleoside Reverse Transcriptase Inhibitor

Prescription/Non-Prescription
Prescription

Caution
Use with caution in patients with renal impairment

Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz Tablets

Take advantage of this hot deal on Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz Tablets-offered at a special rate for distinguished suppliers and traders in India. This fixed-dose, film-coated, capsule-shaped combination delivers glorious efficacy in antiretroviral therapy (ART) for HIV-1 infection. Lavishly crafted for quality and ease, each prescription bottle contains 30 tablets (or as per manufacturer) for once-daily oral dosing. This product is designed for safe handling, with robust packaging, reliable shelf life (24-36 months), and storage below 30C. Act now for superior treatment outcomes!

Application Excellence and Standout Features

Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz Tablets are indicated for the effective management of HIV-1 infection in adults and adolescents. With oral administration as the primary site of application, these tablets offer a distinguished once-daily dosing schedule, simplifying therapeutic routines. Special features include a fixed-dose combination, film-coated exterior for easier swallowing, and capsule shape. These attributes maximize patient adherence and clinical outcomes, making them highly regarded in modern antiretroviral therapy protocols.

Seamless Distribution: Pricing, Port, and Samples

Benefit from our lowest list price and efficient shipment via major Indian FOB ports, ensuring quick and secure delivery. Samples of Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz Tablets are available upon request, adhering to our transparent sample policy designed for serious buyers and regulatory reviews. This enables buyers to evaluate product quality before placing bulk orders, making the procurement process smooth and cost-effective. Unlock value and reliability in every transaction.

FAQ's of Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz Tablets:

Q: How should Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz Tablets be stored for optimal effectiveness?

A: These tablets should be kept in a tightly closed container, stored below 30C in a dry place, and protected from light to preserve their quality and prolong their shelf life.

Q: What is the recommended usage of these tablets in HIV treatment?

A: Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz Tablets are taken orally once daily as part of antiretroviral therapy for adults and adolescents with HIV-1 infection, as prescribed by a healthcare professional.

Q: When should these tablets be avoided or used with caution?

A: Do not use these tablets in patients with known hypersensitivity to any components or severe hepatic impairment. Caution is required for individuals with renal impairment, with close medical supervision advised.

Q: Where can buyers obtain these tablets and are samples provided?

A: Suppliers and traders can source these tablets from India, with shipments dispatched through major FOB ports. Samples are available for evaluation in accordance with the supplier's sample policy.

Q: What are the standout benefits and features of this medication?

A: This product offers a distinguished fixed-dose combination, convenient once-daily dosing, robust packaging, long shelf life, and film coating for easier intake, all supporting improved patient compliance and therapeutic success.

Tell us about your requirement